glp 1 drugs sleep apnea Survey: Providers Want GLP-1s Approved for Dr. Anne Marie Morse Explains

That will hopefully continue to lower prices," said Levin-Scherz

#BloodDoctor #Thrombosis #APS #MedEd To view or add a comment, sign in - : GLP-1 receptor agonists are redefining how we manage type 2 diabetes and obesity and these companies are leading the way: Ozempic, Wegovy, Rybelsus Mounjaro, Trulicity , Also making significant contributions with drugs like Bydureon, Adlyxin, and Soliqua With GLP-1 therapies gaining global traction due to their metabolic and cardiovascular benefits, the competition is fierce and innovation is rapid

International guidelines now recommend use of either drug for most patients with type 2 diabetes [4,5,6]

A Review of practical issues on the use of glucagon-like peptide-1 receptor agonists for the management of type 2 diabetes

The most common abnormality in PCOS is excessive ovarian androgen secretion, present in up to 80% of patients 9,10